Table 2

Previous reports on cyclins D2 and D3 expression by immunohistochemistry in DLBCLs
Reference (reference no.) No. of patients Cut-off line (%) Positive cases (%)
Cyclin D2 Cyclin D3
Hans CP, et al., 2004 [8] 152 30 13 ND
Hans CP, et al., 2005 [9] 200 30 19 62
Amen F, et al., 2007 [10] 80 10 25 ND
Metcalf RA, et al., 2010 [3] 194 20 49 20
Present study CD5+ DLBCLs 51 20 98 35
        CD5 DLBCLs 51 20 28 47

ND, not done.

Igawa et al.

Igawa et al. Diagnostic Pathology 2013 8:81   doi:10.1186/1746-1596-8-81

Open Data